🔎 Trials Near Me

Dachaigh › Galar Crohn › Missouri

Sgrùdaidhean clionaigeach Galar Crohn ann an Missouri

Tha 21 sgrùdaidhean airson Galar Crohn a’ lorg phàirtichean aig làraichean ann an Missouri.

Bailtean ann an Missouri

Teacsa sgrùdaidh oifigeil (Beurla)

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Specialists In Gastroenterology /ID# 283939, St Louis
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07697456

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
  • Siteman Cancer Center at West County Hospital, Creve Coeur
  • University Health Truman Medical Center, Kansas City
  • agus 5 a bharrachd
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT03816345

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

  • BVL Research - Kansas ( Site 0292), Liberty
A’ fastadhÌre 3
Gach aois · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06651281

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  • Mid-America GI Clinical Research ( Site 5130), Kansas City
  • BVL Research - Kansas ( Site 5099), Liberty
  • Washington University School of Medicine ( Site 5058), St Louis
A’ fastadhÌre 3
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06430801

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • SSM Health Medical Group, Bridgeton
  • GI Associates Research, LLC, Columbia
  • Mid America Gastro Intestinal Consultants, Kansas City
  • agus 1 a bharrachd
A’ fastadhÌre 4
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06581328

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

  • GI Associates Research, LLC /ID# 267433, Columbia
  • Bvl Research /ID# 265870, Liberty
  • Washington University /ID# 266938, St Louis
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06548542

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

  • BVL Clinical Research, Liberty
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06233461

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Washington University School of Medicine, St Louis
A’ fastadhÌre 3
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • BVL Clinical Research-Site Number: 8400005, Liberty
  • Washington University School of Medicine-Site Number: 8400075, St Louis
  • Gateway Gastroenterology-Site Number: 8400097, St Louis
A’ fastadhÌre 3
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • BVL Clinical Research-Site Number: 8400005, Liberty
  • Gateway Gastroenterology-Site Number: 8400097, St Louis
A’ fastadhÌre 3
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07184944

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Washington University School of Medicine, St Louis
A’ fastadhÌre 3
Aoisean 2 gu 19 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT04844606

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

  • KAD Clinical Research, St Louis
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07483099

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  • SSM Health DePaul Hospital- St. Louis, Bridgeton
A’ fastadhÌre 2
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06226883

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

  • KAD Clinical Research, St Louis
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07483073

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

  • Mid-America Gastro-Intestinal Consultants, Kansas City
  • BVL Clinical Research, Liberty
  • Washington University School of Medicine, St Louis
A’ fastadhÌre 4
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06045754

DB-3Q for the Treatment of Medically Refractory Crohn's Disease

  • Washington University, St. Louis, St Louis
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT07625293

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

  • Washington University School of Medicine, St Louis
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 5 Ògmh 2026 · NCT06976853

A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

  • Investigational Site Number: 8400013, St Louis
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 27 Màrt 2026 · NCT06958536

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, Bridgeton
  • Mirador Therapeutics Selected Site, Kansas City
  • Mirador Therapeutics Selected Site, Liberty
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 12 Màrt 2026 · NCT07113522

Treatment of Moderate to Severe Refractory Crohn's Disease

  • Washington University in St. Louis, St Louis
A’ fastadhÌre 1/2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 10 Dùbh 2025 · NCT06721962

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy

  • Washington University in St Louis School of Medicine, St Louis
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Samh 2025 · NCT06670638

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.